GlaxoSmithKline logo
Advanced search


Data summary



Access to medicines 2003 2004 2005 2006 2007
Number of countries supplied with preferentially priced ARVs1 56 57 56 51 31
Number of Combivir and Epivir tablets shipped (millions)1 16.2 66.4 126.3 86.3 85.0
Number of generic ARVs supplied under licence from GSK (millions) - - - 120 183
GSK Combivir not-for-profit price ($ per day)2 1.7 0.65 0.65 0.65 0.65
Voluntary licences granted to generic manufacturers for GSK ARVs (cumulative total)3 - 6 7 9 9
Value of products donated through GSK Patient Assistance Program in the US (£ million) 125 203 255 200 194
Research and development          
Expenditure on R&D (£ billions) 2.8 2.9 3.1 3.5 3.3
GSK animal research facilities accredited by the Association for Assessment and Accreditation of Laboratory Animal Care4 7 10 10 10 10
Number of trials published on the GSK Clinical Trial Register (cumulative total) - 143 2,125 2,760 3,089
Ethical conduct          
Number of managers completing certification to the GSK Code of Conduct 9,000 9,600 >12,000 >12,000 >14,000
Number of contacts through our ethics compliance channels5 - 2,580 3,644 5,363 5,265
Employment          
Women in management grades (per cent) 34 35 35 36 37
Ethnic diversity - minorities (US, per cent) 19.5 19.5 19.6 19.8 20.1
Ethnic diversity - ethnic minorities (UK, per cent) - 14.8 14.9 18.3 19.1
Lost time injury and illness rate (cases per 100,000 hours worked) 0.30 0.30 0.30 0.33 0.33
Environment          
Number of contract manufacturers audited 28 35 41 36 37
Energy consumption (million gigajoules) 20 19 20 19 19
Water consumption (million cubic metres) 23 21 22 22 21
Ozone depletion potential from metered dose inhalers (tonnes CFC-11 equivalent)6 782 464 273 186 136
Ozone depletion potential from production (tonnes CFC-11 equivalent) 72 59 51 33 15
Ozone depletion potential from refrigeration and other ancillary uses (tonnes CFC-11 equivalent) 3 3 3 1 1
Volatile organic compound emissions (thousand tonnes) 6 5 5 4 4
Global warming potential from energy sources (thousand tonnes CO2 equivalent) 1,756 1,667 1,716 1,688 1,667
Hazardous waste disposed (thousand tonnes) 58 71 65 70 68
Community investment          
Total community investment expenditure
(£ millions)		 338 328 380 302 282
Value of humanitarian product donations, including albendazole (£ millions) 116 57 41 38 30
Number of albendazole tablets donated for prevention of lymphatic filariasis (millions) 94 67 136 155 150

  1. Includes ARVs sold at not-for-profit and discounted prices. We are unable to collect data for the number of patients treated.
  2. Includes freight and insurance costs. The Médecins Sans Frontières pricing report lists the average cost of generic equivalents.
  3. Only eight are currently in force.
  4. This covers approximately 92 per cent of animals used in GSK facilities.
  5. Includes contacts with line managers, compliance officers, our confidential integrity helplines or off site post office box (in the US).
  6. 2002 to 2004 data do not include inhalers made in Asia.

Trademarks
Brand names appearing in italics throughout this publication are trademarks either owned by and/or licensed to GSK or associated companies.

* Back to top